日辰股份(603755.SH):期待下半年能有好的表現
格隆匯5月29日丨有投資者向日辰股份(603755.SH)提問:如何看待股權激勵計劃所設定的今年業績增長目標?
日辰股份回覆:從一季度的業績表現和公司微觀感受來看,下游消費市場在有序復甦,餐飲企業及門店數量逐步增加、新品切換的活躍度逐步增加。公司將加大產品研發和客户開發的力度,充分發揮股權激勵計劃的激勵作用,齊心協力完成業績增長目標。從公司往年分季度的經營情況來看,三四季度一般會好於一二季度,期待下半年能有好的表現。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.